1.0Cilcarehttps://www.cilcare.com/jprich600338<blockquote class="wp-embedded-content" data-secret="noA1vJMB37"><a href="https://www.cilcare.com/jp/team/veronique-baudoux/">Véronique BAUDOUX</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.cilcare.com/jp/team/veronique-baudoux/embed/#?secret=noA1vJMB37" width="600" height="338" title="“Véronique BAUDOUX” — Cilcare" data-secret="noA1vJMB37" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://www.cilcare.com/wp-includes/js/wp-embed.min.js </script>https://www.cilcare.com/wp-content/uploads/2024/12/Veronique.jpg610763With a decade of experience at Cilcare, Véronique Beaudoux is a Clinical Trial Manager specialized in electrophysiological and electroacoustic assessments. She oversees clinical trials for proprietary therapeutic molecules, including lead product CIL001. Véronique is responsible for drafting clinical protocols, supporting CROs selection, and monitoring study progress, including recruitment. She works closely with clinical, CMC, and regulatory teams to ensure clinical needs are integrated into CMC and regulatory activities and manages the supply of investigational products to clinical centers. In addition, she conducts auditory assessments for observational trials involving diabetic patients and those with neurodegenerative diseases.